Skip to main content
Smart Investors Daily
MF

NYSE · MFC

Manulife Financial Corporation

Financial Services · Insurance - Life

$43.87

Up+$0.32 (+0.73%)

Updated Sep 16, 2026, 12:37 PM

SID Score

7.8/10

Composite research score

Smart Money

58/100

Neutral

Market cap
60.06B
P/E ratio
13.87
Dividend yield
2.86%
52-week range
$30.52 – $45.33
Volume
1.55M
Avg. volume
2.11M

Price performance

MFC price history

1M range · 20 trading sessions · Daily adjusted prices

MFC closed at $43.87 after 20 trading sessions, down 0.36% for the selected period.

Last close
$43.87
Period change
-0.36%
Period low
$42.14
Period high
$44.59
Daily close
View OHLC price history
MFC OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Sep 15, 2026$43.54$43.92$43.30$43.871.55M
Sep 14, 2026$43.30$43.70$43.16$43.55973.44K
Sep 11, 2026$43.86$44.00$43.00$43.49921.09K
Sep 10, 2026$43.04$43.61$42.80$43.481.67M
Sep 9, 2026$43.34$43.34$42.79$42.943.51M
Sep 8, 2026$44.11$44.28$43.33$43.384.07M
Sep 4, 2026$44.37$44.55$44.13$44.341.02M
Sep 3, 2026$43.64$44.655$43.56$44.591.99M
Sep 2, 2026$42.37$43.31$42.26$43.291.9M
Sep 1, 2026$42.38$42.60$41.91$42.142.42M
Aug 31, 2026$42.93$43.09$42.31$42.411.52M
Aug 28, 2026$43.22$43.37$42.555$42.761.91M
Aug 27, 2026$43.00$43.425$42.84$43.151.26M
Aug 26, 2026$43.21$43.415$42.92$43.23941.37K
Aug 25, 2026$43.00$43.185$42.495$43.171.32M
Aug 24, 2026$42.31$42.96$42.31$42.821.78M
Aug 21, 2026$42.48$42.97$42.44$42.515.22M
Aug 20, 2026$43.37$43.43$42.33$42.4712.55M
Aug 19, 2026$44.25$44.25$43.205$43.422.31M
Aug 18, 2026$44.32$44.42$44.03$44.03972.48K

Latest MFC news

The latest Smart Investors Daily articles mentioning MFC.

MFC research

Overview

Company profile and research snapshot.

Company profile

Manulife Financial is one of the Big Three Canadian life insurers. The firm provides life insurance, annuities, asset management, and wealth management products to individuals and group customers in Canada, the United States, and Asia. The Canadian business segment contributes approximately 22% of adjusted earnings. The Asia segment operates across 12 countries and contributes around 36% of earnings, with a significant presence in Hong Kong and Singapore. The US business, which primarily operates under the John Hancock brand, contributes about 23% of earnings. Manulife's global asset and wealth management business contributes approximately 20% of its earnings and had around CAD 1.03 trillion in assets under management and administration as of the end of 2024.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Buy
Average target
$47.00
Implied upside
Analysts
7
MFC recent ratings
DateFirmRatingTarget
Jun 18, 2026CIBC CAPITAL MARKETSOutperform
May 14, 2026SCOTIABANK GBMOutperform
May 14, 2026ARC INDEPENDENT RESEARCHBuy
May 13, 2026TD COWENBuy
May 12, 2026JEFFERIESBuy
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Sep 9, 2026

Manulife Expands Segregated Fund Lineup to Help Canadians Grow and Protect Their Wealth

Manulife Canada, the country's largest life insurance company, today announced the expansion of its segregated fund lineup, adding eight new funds and increasing access to 11 existing funds to deliver greater choice and flexibility for advisors and their clients. The enhanced offering provides exposure to leading investment strategies through both mutual fund and ETF solutions, spanning actively managed and index-based mandates, while preserving the protection, estate planning and wealth transfe

Yahoo · Sep 2, 2026

Hormone Replacement Therapy Use Jumps 228% Among Canadian Women in Peak Working Years: Manulife Data

New data from Manulife Canada's Group Benefits business shows a sharp increase in hormone replacement therapy (HRT) claims. In fact, over the past five years, HRT claims among women aged 45 to 54 have increased by 228 per cent, suggesting more women are seeking treatment and support to manage menopause-related symptoms, as awareness of menopause grows and more women feel empowered to seek treatment.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.